Clinical outcomes among ErbB2+MBC patients treated with lapatinib-capecitabine after trastuzumab progression: Role of early switch to lapatinib (TYCO study).


Abulkhair O., Uslu R., Sezgin C., Bueyuekberber S., Darwish T., Isikdogan A., ...More

CANCER RESEARCH, vol.72, 2012 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 72
  • Publication Date: 2012
  • Doi Number: 10.1158/0008-5472.sabcs12-ot1-1-08
  • Journal Name: CANCER RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Gazi University Affiliated: No